From the Chairmans address.Science that for what we are told is progressing as expected, we are waiting for results, so is big pharma.
"Several big pharma companies are now engaged in discussion with Benitec’s senior management.
In vitro, in vivo and clinical data will be the catalysts for advancing these discussions. The cash raised via the cross-over funding in March 2014 and in the recent NASDAQ listing is being used to advance these programs to a standard required by big pharma companies".
They will report on completion of trial, no material event has occured good or bad (no trial candidate has been cured or deceased) as expected.
Too many other colaborators continuing to use the science so they must see something in it or they would bail!
Time is the factor............................
Can't resist a bargin! I am back in buying.
Hi ho, hi ho, is off to work we go!
- Forums
- ASX - By Stock
- 0.38c
From the Chairmans address. "Several big pharma companies are...
-
-
- There are more pages in this discussion • 32 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne